O que a ciência nos ensina sobre o Câncer de Mama | Felipe Zerwes | TEDxUnisinos

Quick Overview

The presentation by Felipe Zerwes at TEDxUnisinos emphasizes the critical importance of early diagnosis and advanced personalized medicine in combating breast cancer, contrasting poor survival rates in low HDI countries with better outcomes elsewhere, and advocating for public engagement and lifestyle changes to mitigate risk.

Key Points: Breast cancer incidence is projected to increase by 38% and mortality by 68% globally by 2050, with the highest mortality rates (55%) occurring in low Human Development Index (HDI) countries. Being female and aging are non-modifiable risk factors, while lifestyle factors like obesity and alcohol consumption can be modified to prevent 25% of new cases. Early diagnosis significantly improves survival rates; patients diagnosed early have better survival probability compared to those diagnosed with advanced stages, especially in public health systems (P < 0.001 for all patients). Advanced treatments, like the antibody-drug conjugate described (Ado-trastuzumab emtansine), function as targeted 'Trojan horses' to deliver potent chemotherapy directly to tumor cells, minimizing systemic side effects. The speaker calls for greater public participation in health policy decisions, such as public consultations, to ensure equitable access to advanced treatments and technologies within the public health system. The speaker contrasts the high cost of treating advanced-stage cancer versus earlier stages, suggesting that early detection saves both lives and financial resources for the public health system.

Context: Felipe Zerwes, a speaker at TEDxUnisinos, delivers a presentation focused on breast cancer, contrasting global epidemiological trends with the potential of personalized medicine and early detection. He uses striking statistics comparing survival rates between high and low HDI countries and discusses the mechanism of advanced targeted therapies, ultimately calling for greater public awareness and involvement in health policy decisions to improve equitable care access.